Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Speedel completes CHF71.3mm Series E round

Executive Summary

In its mezzanine round, private cardiovascular drug developer Speedel has raised CHF52.1mm ($38.6mm) through DSM Venturing BV (DSM NV's business development arm) and the Novartis Venture Fund.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Convertible Debt
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register